Getting Granular with eCTD v4.0
We talk a lot about the goal of enterprise content strategy for pharma: to help speed up the process of making safe, effective medicines.
Solving the XML Authoring Conundrum for Pharma
“We cannot change the authoring experience.” This, more than anything else, is the message we used to be told (and still hear often) when we suggest a component-based structured authoring environment for medical writers at pharmaceutical companies. The authoring experience using Microsoft Word reigns supreme. Any changes to this interface
Standards Make the Promises of Digital Transformation Possible
The pharma industry is no stranger to standards. Pharmaceutical companies have entire teams devoted to ensuring that all data and content is collected, created, managed, retained, and retired according to regulatory requirements.
Who Owns My Content and Why Isn’t It Me?
Using component-based structured content authoring and having a robust reuse strategy is the only way to produce pharma content at scale. It’s how you produce accurate content efficiently across the enterprise. It’s how you deliver the right content to the right place at the right time, such as when you
XML Standards Provide Rigor and Flexibility for Pharma
The pharma industry has come together to develop technical solutions that speed time-consuming processes and reduce errors that can cause risk to the business and ultimately to patients.
Solving Pharma Content Challenges
In The Unique Challenges of Pharma Content, we discuss challenges faced by pharmaceutical companies in the creation and management of content.
The Unique Challenges of Pharma Content
Most content challenges are ubiquitous, present in every vertical. Processes that don’t scale. Too much content to manage and yet the exact right content never seems to be at hand. Authors must copy and paste and (inevitably) tweak content, wasting time and increasing risk. The challenges of time, cost, and
COVID and Content: The Role of Content in Getting Vaccines to Market Quickly
The COVID-19 pandemic put tremendous pressure on drug-development organizations to accelerate product development far beyond anyone’s wildest roadmaps.
Buy this Book to learn exactly what it takes to deliver personalized experiences at scale.
our recent posts
Get exclusive access to Val’s thoughts and hand-picked content with our newsletter.
“*” indicates required fields
browse by topic
- Additional Resources (3)
- AI Readiness (9)
- Artificial Intelligence (4)
- Blogs (117)
- Books (1)
- Content Development (45)
- Content Management (4)
- Content Quality (19)
- Content Strategy (99)
- Content Transformation (22)
- Conversational AI (1)
- eBooks (6)
- Global Readiness (5)
- Good Words (2)
- Knowledge Management (1)
- Personalization (19)
- Pharmaceutical (31)
- Recordings (14)
- Regulatory Compliance (1)
- Structured Content (3)
- White Papers (5)
- Workplace Practices (1)